Fenugreek compound (N55) lowers plasma glucose through the enhancement of response of physiological glucagon-like peptide-1
Risk Assessment: Evaluate the patient's obesity risk embedded in their genetics, gut microbiome, and insulin metabolism
Its commonly used in doses ranging from 500 mg to 2,000 mg per day
The episode dives into safe detox practices, industry transparency, and the values of collaboration, integrity, and holistic care in transforming individual and community health
With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide
The formula was developed by PhD scientists and industry experts